Leukemia-differentiating activity expressed by the human melanoma cell line LD-1

Michael B. Lilly, Andrew S. Kraft

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

We have identified a leukemia-differentiating activity (LDA) in medium conditioned by the LD-1 melanoma, a G-CSF secreting human tumor line. Partially-purified LDA induces HL-60 cells to produce superoxide, become phagocytic, and to develop macrophage-like morphology and surface markers. The LDA markedly suppresses clonal growth in agar of HL-60 cells, and cells of the human myeloid leukemia lines PBL 985 and K562, but does not suppress clonal growth of the B-lymphoblast lines Raji and Daudi. The molecular weight of this material is approx. 40,000 daltons. It can be separated from the bulk of the colony stimulating activity on phenyl sepharose chromatography. The LDA is not neutralized by antibodies to G-CSF, GM-CSF, IFNα, IFNγ, TNF, urokinase, and tissue plasminogen activator, and is not inhibited by preincubation with aprotinin. The LDA in conditioned medium may be different from previously described differentiating factors, and may represent an additional class of human growth regulators.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalLeukemia Research
Volume12
Issue number3
DOIs
StatePublished - 1988
Externally publishedYes

Keywords

  • HL-60
  • Leukemia
  • differentiation
  • melanoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Leukemia-differentiating activity expressed by the human melanoma cell line LD-1'. Together they form a unique fingerprint.

  • Cite this